Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Anthem to buy Cigna to create biggest U.S. health insurer

Published 07/24/2015, 12:12 PM
Updated 07/24/2015, 12:12 PM
© Reuters. The office building of health insurer Anthem is seen in Newbury Park, California

© Reuters. The office building of health insurer Anthem is seen in Newbury Park, California

By Ankur Banerjee and Ransdell Pierson

(Reuters) - Anthem Inc said on Friday it would buy Cigna Corp (NYSE:CI) for about $54.2 billion, a deal that would create the largest U.S. health insurer by membership and accelerate the consolidation of an industry from five national players to three.

The proposed acquisition — the biggest ever in the health insurance industry — comes three weeks after Aetna Inc (NYSE:AET) agreed to buy Humana Inc (NYSE:HUM) for $37 billion.

Health insurers are finding it tougher to raise prices following the roll-out of President Barack Obama's healthcare law, while grappling with soaring costs for a growing list of innovative new medications such as some new cancer drugs that cost $100,000 annually for patients.

State insurance regulators and federal antitrust authorities are expected to aggressively scrutinize how both of the proposed health insurer acquisitions will affect competition for Medicare and individual and commercial insurance.

Under the deal, which the companies expect to close in the second half of 2016, Anthem Chief Executive Joseph Swedish would serve as CEO and Chairman of the combined company. Cigna CEO David Cordani would be president and Chief Operating Officer.

In a joint conference call with industry analysts, Swedish said that Anthem has had no discussions "at all" with regulators ahead of the deal announcement, but was confident it will receive their approval.

Shares of Cigna on Friday were trading at $147.64, far below their $188 per share value under the announced deal, suggesting significant Wall Street skepticism over whether it will survive antitrust scrutiny.

"Strategically and financially it's very attractive, but they will face regulatory scrutiny," said Ana Gupte, analyst with Leerink Partners. "They also both possibly face divestitures and may have to make concessions to consumers to make the merger go through."

The same apparent wariness of approval has been seen with Aetna's planned purchase of Humana. Humana shares are trading in the $183 range, well below the value of Aetna's cash-and-stock offer of $230 per share when it was first announced.

Both Anthem and Cigna would be liable to pay the other a fee equivalent to 3.8 percent of the deal's value if either of them walk away from the planned merger.

BIGGER THAN UNITEDHEALTH

Anthem and Cigna are two of just four major insurers that administer self-insured plans for major companies. The other two are UnitedHealth Group Inc (NYSE:UNH) and Aetna. The combined company would have about 53 million members. UnitedHealth had 45.86 million members as of June 30.

Growing concerns about market concentration came into sharp focus earlier this year when regulatory concerns scuttled Comcast (NASDAQ:CMCSA) Corp's $45 billion bid for Time Warner Cable Inc (NYSE:TWC).

Anthem said it will pay $103.40 in cash and 0.5152 of its shares for every Cigna share. The deal is valued at $183.36 per share based on Anthem's Thursday close of $155.21. Anthem said the offer is valued at $188 per share, based on its unaffected share price as of May 28 before media reports surfaced that the two companies were in talks.

The equity portion of the offer is valued at $49.11 billion, according to Reuters calculations based on 261.2 million Cigna shares outstanding as of March 31.

Swedish said Anthem's mainstay Blue Cross/Blue Shield insurance coverage requires the company to maintain a concentrated focus on that business, according to Blue Cross rules.

"We will remain Blue," Swedish said on the conference call, adding that Anthem feels confident that even after acquiring Cigna and its core Medicare Advantage plans, the combined company will satisfy "the Blue rules."

The company has said the deal will help it reduce costs and allow it to negotiate lower prices with doctors and hospitals.

(The) spirit of our collaboration going forward is total collaboration," Swedish said, saying his and Cordani's different roles and responsibilities "are perfectly aligned."

Swedish said he intended to remain CEO of the combined company for two years, and afterward become chairman.

Anthem's lead financial adviser is UBS Investment Bank. Credit Suisse (SIX:CSGN) also served as financial adviser, and White & Case LLP as legal adviser.

© Reuters. The office building of health insurer Anthem is seen in Newbury Park, California

Morgan Stanley is Cigna's financial adviser and Cravath, Swaine & Moore LLP its legal adviser.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.